Physician profile
Gary A Curran
NPI 1346225232
$561.48
in general payments reported to CMS, 2019-2025
14 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.66 · 2020: $15.76 · 2021: $45.38 · 2022: $80.87 · 2023: $123 · 2024: $47.45 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $190.86 | 2021-2024 | Wegovy |
| Abbvie INC. | $53.45 | 2025 | |
| Baxter Healthcare | $50.23 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.04 | 2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $36.09 | 2025 | Breztri, Nexium |
| Abbott Laboratories | $32.40 | 2019-2020 | |
| Almatica Pharma LLC | $31.38 | 2022 | |
| Dexcom, INC. | $24.34 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $24.11 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.47 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $17.16 | 2025 | Shingrix, Arexvy |
| Nevro Corp. | $15.02 | 2019 | |
| Exact Sciences Corporation | $14.23 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $13.70 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Curran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.